Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
Biofrontera Inc. (BFRI)
Company Research
Source: GlobeNewswire
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three and six months ended June 30, 2024 and provided a business update. Highlights from the second quarter of 2024 and subsequent weeks included the following: Total revenues for the second quarter of 2024 were $7.8 million, a 34% increase from the same period of the prior yearCash and cash equivalents were $4.4 million as of June 30, 2024, compared with $1.3 million on December 31, 2023Biofrontera announced the launch of a new, FDA-approved red-light source, the RhodoLED® XL lamp in June and installed several lamps by June 30th, 2024Took control of all clinical trials relating to Ameluz® in the US, allowing for more effective cost management and direct oversight of trial efficiencyBiofrontera raised an additional $8.0M in May 2024 from the exercise
Show less
Read more
Impact Snapshot
Event Time:
BFRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BFRI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BFRI alerts
High impacting Biofrontera Inc. news events
Weekly update
A roundup of the hottest topics
BFRI
News
- Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference [Yahoo! Finance]Yahoo! Finance
- Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities ConferenceAccesswire
- Biofrontera Inc. (NASDAQ: BFRI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $7.00 price target on the stock.MarketBeat
- Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024Accesswire
BFRI
Earnings
- 8/14/24 - Beat
BFRI
Sec Filings
- 9/12/24 - Form SC
- 8/14/24 - Form 8-K
- 8/14/24 - Form 10-Q
- BFRI's page on the SEC website